Experimental Biology and Medicine
 Journal of the Society for
Experimental Biology and Medicine
Effective with submissions beginning July 1, 2010, there will be no page charges
for articles where the first or corresponding author is an SEBM member in good standing.
All manuscripts should be submitted to:
http://ebm.allentrack.net
Please read the following instructions prior to submitting
your manuscript:
Instructions for Authors
These instructions comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals
formulated by the International Committee of Medical Journal Editors (for further details, see the ICMJE site) .
Aims and scope
Experimental Biology and Medicine is particularly
appropriate for publication of papers that are multidisciplinary in
nature, are of potential interest to a wide audience, and represent
experimental medicine in the broadest sense of the term. However,
manuscripts reporting novel findings on any topic in the realm of
experimental biology and medicine are most welcome. We particularly
encourage submission of manuscripts that describe results of studies
that require an interdisciplinary approach to biomedical issues.
Categories currently listed in EBM are: Anatomy/Pathology; Biochemistry
and
Molecular Biology; Cell and Developmental Biology; Endocrinology and
Nutrition;
Immunology/Microbiology/Virology; Neuroscience; Pharmacology and
Toxicology;
Physiology; Bioimaging; Biomedical Engineering; Bionanoscience;
Genomics, Proteomics, and Bioinformatics; Stem Cell Biology; Systems
Biology and Translational Research. Authors should indicate their
preference of category,
although the final decision of reviewing Associate Editor and section
Editorial Board rests with the Editor-in-Chief.
Editorial Policy
Covering letter: The covering letter is important. To help the Editor in his
preliminary evaluation, please indicate why you think the paper suitable for publication; the
letter should explain how your paper is innovative, provocative, timely, and of interest to a
broad audience. The letter should list any paper on related topics by any of the authors that
have been published within the past year or that are in review or in press. The letter must
state that the non-signing author(s) have read and approved the manuscript. Any person cited in
the manuscript as a source of "personal communication" or "unpublished data" must provide
signed approval of such citation.
Peer Review: Two reviewers will generally evaluate each manuscript
on the basis of scientific rigor of the experimental design, adequacy
of the data, validity of the conclusions, importance and originality of
the studies, adequacy of the literature citations, clarity of the
presentation, and interest to the Journal's readership. Manuscripts may
be returned to the authors without detailed review if, in the opinion
of the Editor-in-Chief, they fall outside the scope of interests of the
Journal's readership or if they are not written in clear, concise and
grammatical English.
Manuscripts will be given a quality (priority) ranking by each
reviewer. Those manuscripts with low priority rankings will not be
accepted even though they may have been classed as generally
acceptable. If reviewers differ significantly in their opinions,
decision will be based on the priority rankings and/or the opinion of
an additional reviewer (arbiter). Manuscripts returned after revision
based upon reviewers' comments will be sent back to the original
reviewers together with the authors' responses.
The reviewers' comments will be held in confidence except as
follows: (a) the reviewers' comments may be sent, in whole or in part,
to the corresponding author;(b)after revision, each reviewer's comments
will be sent, in whole or in part, to the other reviewers of the
manuscript: and (c) in the event that there is a significant difference
in opinion between or among the reviewers, the manuscript may be sent
to an additional reviewer (arbiter) together with the comments, in
whole or in part, of the other reviewers. In all cases, anonymity of
the reviewers will be maintained.
Ethical approval: All research submitted for publication must
be approved by an ethics committee.
Use of Human and Animal Subjects and Recombinant DNA:
Studies involving human subjects must conform to the ethical
standards set by the Belmont Report, Ethical Principles and Guidelines
for the Protection of Human Subjects of Research; must have been
reviewed and approved by the appropriate institutional Review Board
(IRB); and must be presented in such a manner as to assure preservation
of the anonymity of the subjects. It must be stated in the Materials
and Methods section of the article that the study had been approved by
the responsible IRB and that informed consent was obtained from
research subjects or it must be explained why IRB review and /or
informed consent were not required.
It is the Journal's policy that all studies involving the use
of animals be conducted in compliance with applicable laws and
regulations as well as the principles expressed in the National
Institutes of Health, USPHS, Guide for the Care and Use of Laboratory
Animals, and that the studies be conducted on animals that were
lawfully acquired. Use of animals must have been approved by the
Institution's Animal Care and Use Committee (IACUC) and this must be
stated in the Materials and Methods section of the article. If the
study was conducted in a jurisdiction where such review is not
required, this should be noted in the Materials and Methods section.
Experiments involving recombinant DNA must have been reviewed and
approved as required by applicable laws and regulations.
Financial Support and Conflict of Interest:
All grant, contract and industrial support of the work
included in the manuscript must be acknowledged in a footnote to the
title of the manuscript. Commercial relationships of any of the authors
that might be viewed as representing a conflict of interest must be
disclosed in a footnote to the applicable author's name. Such
disclosure should be made on a separate page as it will not be sent to
reviewers or influence editorial decisions but will be included in the
published paper.
Permissions: All previously published material must be accompanied by the
written consent to reproduction of the copyright holder. An acknowledgement of permission
should be included at the relevant point in the paper, and a full reference to the
original place of publication should be included in the reference list.
Copyright: Authors of accepted manuscripts will be required to allocate copyright to
the Society for Experimental Biology and Medicine (SEBM).
Disclaimer: Articles and other materials published in Experimental Biology and Medicine represent
the opinions of the author(s) and should not be construed to reflect the opinions of the Editor(s)
or the Society.
Authors of manuscripts describing original nucleotide or amino
acid sequences must submit the sequence to Gen Bank and obtain
an accession number from Gen Bank before publication of the
manuscript. The accession number should be included in the manuscript
as a footnote or in the appropriate figure legend.
When, as a result of reviewers' comments, it is necessary to
revise a manuscript, it is recommended that, unless additional studies
are required, the authors should resubmit the revised manuscript
promptly; a delay of longer than four months may result in the revised
manuscript receiving a lower priority.
If you have any questions regarding submission, please contact
the SEBM office:
Tel: 201-962-3519
Fax: 201-962-3522
e-mail: sebm@inch.com
Types of Articles
Original Research Articles: Manuscripts are accepted for review with the understanding
that the same work has not been and, if accepted by EBM, will not be
published elsewhere nor is presently submitted elsewhere; and that its
submission for publication has been approved by all of the authors (as
confirmed by the covering letter). Unnecessary subdivision of a study
into several manuscripts is not acceptable. If any material published
previously is included, for clarity or other reasons, this should be
indicated with appropriate citation in the manuscript.
One copy of any material that might be regarded as "duplicate
publication," such as preliminary reports (including reviews, symposia
and proceedings) or other publications (submitted, in press or
published) containing data or other material included in the submitted
manuscript, must be sent to the Editor when the manuscript is
submitted. Clearly label such material so as to avoid any confusion
with the submitted manuscript. Normally it is regarded as acceptable to
include in a detailed journal article material that has been presented
previously in summary form in reviews, symposia, or conferences,
provided appropriate citation is included.
Brief Communications:
Manuscripts describing focused studies that are concise and of
high impact to a field will be published as Brief Communications.
This format is intended for the presentation of scientifically sound and
novel research in a clear and concise fashion. The body of the paper
should not exceed nine (9) pages of double-spaced text with references.
Tables and Figures must also be kept to a minimum (no more than four).
Formatting should otherwise follow the requirements for Original Research Articles.
Minireviews:
The journal publishes review articles under the section
heading "Minireviews." Although there is no page limit, the reviews are
generally short (~20 pages of double-spaced text with references). They
should reflect the state-of-the-art of the area being reviewed and
often include a brief history of the field. There is no need to include
an exhaustive literature survey. Emphasis upon a particular hypothesis
or point of view or upon the personal opinions or interpretation of the
writer or upon the work of the writer's laboratory is appropriate,
provided that this focus is clearly indicated in the paper. Most
reviews are submitted in response to an invitation from the
Editor-in-Chief, and are subjected to the usual review
process prior to publication. Unsolicited reviews and reviews solicited
by the Associate Editors need to be approved by the Editor-in-Chief
before
receiving peer review.
Comments:
The Journal, at the Editor-in-Chief's discretion, will
publish, under the section heading "Comments," letters or essays from
readers discussing articles that have recently appeared in the Journal
or other timely topics of interest to the Journal's readership. The
author of a letter or essay which is published accepts full
responsibility for the contents of the letter. Letters discussing a
published article may for example include supporting information,
clarifications, criticisms, corrections, alternate interpretations or
perspectives. Such letters will be sent to the corresponding author of
that article prior to publication. If the corresponding or other author
wishes, her/his response will be published together with the original
letter. At the discretion of the editor, essays or letters discussing
controversial issues may be sent to persons representing alternative
viewpoints who will be encouraged to provide responses. If the Editor
decides to publish such responses, they will be sent to the original
author for comments prior to publication. In some cases, the Editor-
in-Chief may send a letter or essay for outside review prior to
deciding whether to publish it. The Society reserves the right to edit
these communications without materially changing their meaning.
How to submit a manuscript
Only manuscripts submitted via the online manuscript submission and peer
review site, which can be found at http://ebm.allentrack.net will be
considered for publication.
Please note the following forms must be completed on submission:
EBM
Mandatory Submission
Conflict of Interest Disclosure form
Assistance with English
If English is not your native
language,
you may find it helpful to obtain assistance in writing your papers
before submitting
them to EBM. This may not only save time in the review process but also
increase the
accuracy of your submission. You can find help in scientific writing at
several companies
that include:
www.biosciencewriters.com
www.bostonbioedit.com
www.prof-editing.com
Please note that neither EBM nor SEBM has used these services
and are unable to comment on the quality of their work.
Tables and figures must be submitted as separate individual files, in which case the files
should be uploaded in the following order: (1) main text, including title page, abstract, references
and figure legend(s); (2) tables; (3) figures; and (4) supplementary files.
File formats: Text files must be saved in .doc or .rtf format. Other suitable formats include
.tif, .jpg, and ppt for photographic images, .xls for graphs produced in Excel, and .eps for other
line drawings.
How to prepare a manuscript
Formatting: Manuscripts should be as concise as possible, yet
sufficiently detailed to permit critical appraisal, and should
generally not exceed 40 typed pages (including tables, charts and
references). They must be submitted using double line-spaced, unjustified text throughout,
with headings and subheadings in bold case. Press 'Enter' only at the end of a paragraph,
list entry or heading.
Title page: The first page should contain the full title of
the manuscript, a short title, the author(s) name(s)and affiliation(s), and
the name, postal and email addresses of the corresponding author, as well as a
full list of declarations.
The title should be a declarative statement of key
findings and should be limited to 15 words. Use of abbreviations in the
title should generally be avoided. Research articles should be divided
into an Abstract, Keywords, Introduction, Materials
and Methods, Results, and Discussion sections.
Abstract: An abstract of no more than 300 words must accompany
all articles and should not be structured.
Tables. Tables must be prepared using the Table
feature of the word processor. Tables should not duplicate information
given in the text, should be numbered with Arabic
numerals and cited consecutively in the text. Each table should be
titled and double-spaced on a separate sheet. Refer to current issues
of Experimental Biology and Medicine for the acceptable style
of tables. The title of each table should clearly indicate the nature
of the contents, and sufficient experimental detail should be included
in footnotes to the entries in the table to permit the reader to
interpret the results without reference to the text. Units must be
clearly indicated for each of the entries in the table.
Figures. All figures should be cited consecutively
by Arabic numerals in the text with figure legends typed on a separate
sheet. Legends should contain sufficient experimental detail to permit
the figures to be interpreted without reference to the text. Units
should be clearly indicated in the figures themselves. All figures and
illustrations are to be submitted individually in such form as to permit
photographic reproduction without retouching or redrawing. Line
drawings should be no larger than 8.5 x 11.5 inches overall (21 x 27.5
cm). The lettering should be large enough to allow a reduction of two
thirds.
Line drawings should be produced eletronically and clearly labelled using
sans serif font such as Arial. Graphs may be supplied as Excel
spreadsheets (one per sheet). Other line drawings should be supplied in a
suitable vector graphic file format (e.g. .eps).
All photographic images should be submitted in camera-ready form (i.e. with all
extraneous areas removed), and where necessary, magnification should be shown
using a scale marker. Photographic images must be supplied at high resolution,
preferably 600 dpi. Images supplied at less than 300 dpi are unsuitable for print
and will delay publication. The preferred file format is .tif.
Manufacturer names: Please note that when manufacturer names are used in the text,
the location (city, state, country) of the manufacturer should also be included.
Footnotes. Footnotes in the text should be
identified by superscripts consisting of Arabic numerals; footnotes in
the tables should be identified by superscript *, †, ‡, §, **, etc., and placed at the bottom of the table.
"Statement of Author Contributions and Acknowledgments" should be
typed on a separate page and placed at the end of the text pages.
Authors must include a statement that specifies the actual contribution of each
coauthor to the completed work. Formatting of the Statement of Author Contributions
is illustrated by the following example:
"All authors participated in the design, interpretation of the studies and analysis
of the data and review of the manuscript; MPV, MNS, KAM, and YZ conducted the
experiments, RJS supplied critical reagents [or animals] (specify), RAS and WEZ wrote the
manuscript, and XYZ contributed [other] (specify)."
Individuals whose contribution does not reach the level required for their inclusion as an
author should be acknowledged in the traditional way, with their full names(s) given. For
example, "The authors thank Dr. John Doe for advice in statistical analysis".
The corresponding author must verify that all individuals who made contributions to this study are included
either as authors or are acknowledged at the end of the paper.
References: Citations should be used to provide appropriate
attribution and credit to previous investigators. Authors are responsible for
verifying them against the original source material. Extensive citation
should be avoided, if possible, while adhering to the applicable
conventions of the scientific community. Authors are responsible for
obtaining permission to reproduce from the appropriate sources cited in
the text. RSM Press uses the Vancouver referencing system.
References should be arranged numerically at the end of the
manuscript and cited in the text with Arabic numerals in parentheses,
set on the text line. The references should be numbered consecutively
in order of their citation and include the names and initials of all authors. Publications
for which no author is apparent may be attributed to the organization from which
they originate. Simply omit the name of the author for anonymous journal articles - avoid
using 'Anonymous'. Punctuation in references should be kept to a minimum as shown in the following
examples:
1. Baynes J, Dominiczak M. Medical Biochemistry. Mosby, 1999
2. Abozguia K, Phan TT, Shivu GN, Maher A, Ahmed I, Freeneaux MP.
Insights into how to conduct a clinical trial in the UK. J R Soc Med 2007;100:469-72
"Personal communication," "unpublished," and "submitted"
must be excluded from the reference list and cited in a footnote. If a
manuscript being cited has been accepted for publication, include it in
the reference list, giving journal, volume, year as available. In
general, citation of numerous abstracts is discouraged, although
acceptable if necessary to provide proper attribution or credit.
Trade name, popular name or abbreviation when first used
must be preceded by the chemical, scientific or technical name;
thereafter, any of these names or abbreviations may be used. Trade
names should begin with a capital letter. Structural formulas of
chemicals should be used only when absolutely necessary.
Abbreviations: Symbols and abbreviations should be those currently in use.
Authors should not create new abbreviations and acronyms. The RSM's book Units, Symbols and
Abbreviations provides lists of approved abbreviations.
Units: All measurements should be expressed in SI units.
Statistics: If preparing statistical data for publication, please
read the statistical guidelines.
Proofs, Page/Color Charges and Eprints
1. Proofs will be sent by email to the designated corresponding author
as a PDF file attachment and should be corrected and returned promptly; corrections
should be kept to a minimum. Authors will be charged for excessive changes.
2. Colored illustrations will be published only if the authors
cover the costs.
3. Authors are required to pay a part of the cost of publication in the form of a page charge
of $70 per page. Effective with submissions beginning July 1, 2010, there will be no page charges
for articles where the first or corresponding author is an SEBM member in good standing. Member authored papers
are assessed a reduced color print fee.
Authors lacking funding from grant or other sources may apply at the time of submission for a waiver of page
charges. Apply for a waiver of page charges on institutional letterhead at the time of submission.
The letter can be sent electronically to sebm@inch.com, faxed to 201-962-3522 or mailed to
SEBM, 130 W. Pleasant Avenue, #334, Maywood, NJ 07607.
Applications must be endorsed by a senior institutional official
verifying that no funds are available for paying page charges. A waiver of page charges
will not be granted once an initial decision has been rendered on the
manuscript.
Reprint orders of 1,000 or more should be discussed with
the publisher and authors are generally expected to discourage
circulation of reprints for commercial purposes.
A PDF eprint of each published article will be supplied free of charge to the author for
correspondence; hardcopy offprints may be ordered from the publisher when the proofs are returned.
Top of Page
|
